On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Nutranomics, Inc. (NNRX) Success Driven By Emerging Global Health Trends, Comprehensive Educational and Nutritional Solutions

NutraNomics® has developed a considerable brand presence since the roll out of their line of nutritional food products back in 1995, accelerated by mounting global health trends which run parallel to NNRX’s own guiding philosophy that education and self-awareness are crucial components for maximizing health and longevity. The company continues to lead the way today as a dominant R&D force in the world of high-quality vitamins and supplements, offering a comprehensive array of gluten-free, non-GMO, whole food-based products which constitute a revolutionary alternative to all of the synthetic, chemical-based vitamins and supplements currently found on most store shelves. Part of the NNRX approach, and another big reason for the company’s success, has been their continued teaching efforts through the educational portion of the company, Health Education Corporation®, which is dedicated to providing the latest insights and guidance in health, nutrition, and wellness to consumers.

NNRX’s product portfolio addresses a massive, growing global market with a combined one-two punch of premium quality vitamins/supplements and the crucial healthy living guidance to go along with those products, a type of educational initiative about proactive health decisions seemingly absent in the modern medical industry. We are now seeing systemic health crises throughout the western world linked to poor diet and sedentary lifestyle and those same trends are now starting to crop up all over the rapidly modernizing world. The 2014 Global Supplement and Nutrition Industry Report, put out by one of the top research publishers in the space today, Nutrition Business Journal, indicates that the global supplement market hit roughly $96B in 2012 (28% supplements, 29% natural and organic foods, 32% functional foods, 11% natural/organic personal care and household) and most likely climbed 8% to around $104B just this last year. Little wonder as the U.S. is in the vice-like grip of a full-blown obesity epidemic according to National Center for Health Statistics data from 2012, with over 35% of the adult population obese and headed for 44% in every state by 2030 if underlying causes remain unchanged (Trust for America’s Health/Robert Wood Johnson Foundation, 2012). NNRX understands the underlying phenomenology on obesity extremely well and has gone to great lengths to formulate solutions for what is now considered a complex disorder and which is a major risk factor for cardiovascular disease, diabetes, cancer, stroke, and hypertension.

In fact, founder, Chairman and CEO of NNRX, Dr. Tracy K. Gibbs, who is also the company’s chief product formulator, spearheaded development of the company’s dietary and supplement protocol for heart disease, which focuses on the very latest university studies indicating that inflammation related to C-Reactive Protein may be vastly more important than cholesterol (the typical metric) for determining heart health. The company’s dietary protocol for heart health emphasizes cutting out low fat foods and trans fatty acids from products like margarine, which disrupt the body’s balance of good fats and is geared more towards reducing overall C-Reactive Protein levels. This protocol is then enhanced through the use of NNRX’s Lipid Systemic Enzyme supplement to aid digestion of all foods, but particularly fats and lipids, helping to restore proper metabolism and improve oxygen delivery by cleaning up the plasma (otherwise rife with triglycerides, urates, and undigested foods), while subsequently reducing stress on the liver. Further supplementing this protocol with NNRX’s new All Omega product, a 100% natural fish oil from Salmon (non-distilled or CO2 extracted), as well as their PhytoNutrient (for chasing out free radicals, softening up the capillaries for improved circulation and naturally fighting inflammation) and The Works products (broad-spectrum mineral content aids fat assimilation while increasing energy and fortifying the body’s own immune system), can yield significant improvements when it comes to heart health. This overall healthy solution set of protocols embodies a perfect example of where the long-term potential is for NNRX as prevailing health trends continue to pick up steam.

American Heart Association data from 2011 indicates that coronary heart disease alone cost around $108.9B/year just here in the United States. According to more recent 2014 statistics on heart attacks, a whopping 720k or more Americans have an attack every year, the majority of which are first-timers. Furthermore, almost half of those first time heart attacks occur outside a hospital, clearly indicating the lack of education in the general population about the onset of heart disease and its symptoms. NNRX has a clear business model to strike with and the iron gets hotter by the day. Not just here in the U.S. mind you, but all around the globe, as more and more people find themselves at a desk, leading a sedentary lifestyle where their diet is also devoid of the natural plant and food-based nutrients their bodies need to maintain optimum health.

The quality and safety of NNRX’s natural, American-made products (rolling out of cGMP-compliant and FDA-approved facilities) is stark contrast to the synthetic multi-vitamins and other typical fare consumers find on the shelf today, often sourced from the same, tiny handful of Chinese chemical producers. Food-based products like those offered by NNRX feature optimum bioavailability and are rapidly taken up/readily recognized by tissues in the body. Such highly bioavailable nutrients are essential for cellular health and represent a new paradigm compared to the synthetics found in a typical competitor’s products, which are largely rejected by the body or only marginally effective, with the vast majority of what the consumer has paid for ending up flushed out of the body as waste. The premium bioavailability in the company’s product portfolio is due to both NNRX’s proprietary Glycoprotein Matrix® technology, which allows the company to extract high concentrations of vitamins and minerals in their natural form, and also due to their patented Assimilation Enhancing System®, a powerful mix of mineral cofactors and planet-based enzymes that further increases the body’s ability to effectively utilize the natural ingredients.

Tighter regulations on the sector which are emerging globally, ranging from stricter Chinese registrations and enforcement to new “herbal medicine” standards in England, collectively represent vast, burgeoning end markets addressed by NNRX’s superb product line up. The same trend in Brazil is essentially moving all of Latin America in this tighter regulatory direction as well, due primarily to Brazil’s role as the largest regional Latin American market. NNRX is well equipped to hit hard and fast across the global stage, with a slick e-commerce site, growing retail presence and highly-trained sales reps serving key markets in the US and Canada, as well as in Japan, Korea, Malaysia, the Philippines, Singapore, Taiwan, and Poland.

Speaking of the Philippines, NNRX inked a key expansion deal towards the end of January this year there with one of the pioneers and trend setters in multi-level marketing, Philippine health and natural products distribution giant, UNO International Corp., shortly before which NNRX CEO Gibbs had given an influential speech at the UNO Regional Convention in Manila. This key deal with the only ISO-certified MLM in the Philippines was announced just two days after NNRX got the first of what is anticipated to be many more purchase orders from UNO. This initial purchase order was for 20k bottles of the company’s exceedingly popular enzyme formulations, which will be distributed by UNO’s network throughout the Philippines.

More info on Nutranomics is available at www.nutranomics.com

Let us hear your thoughts: NutraNomics, Inc. Message Board

Archives

Select A Month
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered